A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer

• Status: RECRUITING
• Trial end date: 2027-12-01

Summary

This study aims to investigate toripalimab with chemotherapy in participants with nasopharyngeal cancer.

• Phase: PHASE4

Details

• Lead Sponsor: Coherus Oncology, Inc.
• Treatments: Carboplatin; Cisplatin; Gemcitabine; toripalimab